Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Doc Wire News,
This article was originally published here Thromb J. 2021 Nov 15;19(1):87. doi: 10.1186/s12959-021-00337-z.